Tetraethylammonium-Sensitive ventricular repolarization in diabetic rat myocardium: effects of rosiglitazone
ARCHIVES OF ENDOCRINOLOGY AND METABOLISM, cilt.70, sa.6, ss.1-10, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 70 Sayı: 6
- Basım Tarihi: 2026
- Dergi Adı: ARCHIVES OF ENDOCRINOLOGY AND METABOLISM
- Derginin Tarandığı İndeksler: Scopus, Science Citation Index Expanded (SCI-EXPANDED), MEDLINE, Directory of Open Access Journals
- Sayfa Sayıları: ss.1-10
- Çukurova Üniversitesi Adresli: Evet
Özet
Objective: To examine ventricular action-potential responses to tetraethylammonium (TEA), a non-selective potassium-channel
blocker, in streptozotocin-induced diabetic rats and determine whether rosiglitazone modifies these responses. Materials
and methods: Male Wistar rats were assigned to Control (C), Control plus Rosiglitazone (C+RSG), Diabetic (D), or Diabetic plus
Rosiglitazone (D+RSG) groups. Diabetes was induced with streptozotocin (45 mg/kg, intravenous). Resting membrane potential
(RMP), action potential amplitude (APA), and half-repolarization time (½RT) were recorded from isolated left ventricular
papillary muscles before and after TEA administration (2 mmol/L). Results: At week 8, blood glucose was 563 ± 29 mg/dL in
diabetic rats and 98 ± 6 mg/dL in controls (p < 0.001). Rosiglitazone reduced the diabetic value to 336 ± 25 mg/dL (p < 0.05 vs. D).
TEA increased ½RT from 18 ± 1 to 38 ± 2 ms in controls (+20 ms) and from 60 ± 3 to 65 ± 3 ms in diabetic myocardium (+5 ms).
Diabetic preparations had higher post-TEA ½RT because repolarization was prolonged at baseline; however, the absolute TEAassociated
increment was smaller than in controls. TEA also increased APA in untreated control and diabetic preparations. Conclusion:
Diabetes was associated with marked baseline prolongation of ventricular repolarization. The smaller absolute ½RT
increment in diabetic myocardium does not support enhanced TEA responsiveness. Because TEA is non-selective, the findings
reflect an integrated response to TEA-sensitive potassium conductances rather than dysfunction of a specific current subtype.
Rosiglitazone modified selected electrophysiological responses without normalizing diabetic repolarization.
Keywords: Diabetes mellitus; diabetic cardiomyopathy; ventricular repolarization; potassium channels; tetraethylammonium;
rosiglitazone; cardiac electrophysiology